Condensation of 4-phenyl-1H- [1, 5] heterocyclic substituted benzodiazepines at position 3, viz; pyrazole 8, isoxazole 9, pyridines 10 and 11, 1,3-dithiine 12, and 1,3-thiazine 13 derivatives.
3 desired derivatives of [1, 5] benzodiazepine, starting from 3-((4-oxo-4H-chromen-3-yl)methylene)-4-phenyl-1H- [1, 5] benzodiazepin-2(3H)-one (3).
Results and Discussion
3-((4-Oxo-4H-chromen-3-yl)methylene)-4-phenyl-1H- [1, 5] benzodiazepin-2(3H)-one (3) was prepared by condensation of equimolar amounts of 4-phenyl-1H- [1, 5] benzodiazepin-2(3H)-one (1) [22] and 3-formylchromone (2) [23] , in presence of freshly fused sodium acetate, in 60 % yield. Interestingly, 14-chromenyl [1, 5] benzodiazepino [2,3:6,5] pyrano [2,3-b] [1, 5] benzodiazepine 4 was separated as byproduct, in 33 % yield (Scheme 1). It was found that yield of both compounds 3 and 4 is dependent on molar ratio of reactants. Notably, starting with excess molar amount of aldehyde 2, double ratio, gave compound 3 in 90 % yield, while on using half ratio of aldehyde 2 a 2:1 molar ratio led to compound 3 in only 20 % yield (Table 1) . Obviously, condensation of diazepinone 1 with aldehyde 2, leading to methylene derivative 3, is subsequently underwent nucleophilic addition of another diazepinone molecule. Earlier, similar cyclization type was reported by Haas et al. [24] , in which the adduct intermediate underwent an intramolecular cyclization via in situ elimination of a water molecule, accomplishing formation of a trinuclear ring system. The structure of both compounds 3 and 4 was established on basis of their spectral and analytical data. 1 H NMR spectrum of compound 3 showed two singlet signals at δ 7.03 and 8.59, corresponding to methylene and -chromone protons, respectively. 13 and left to stand at room temperature over-night to give crystalline needle-like deposits which were collected by filtration to afford compound 4. 
3-((4-Oxo-4H-chromen-3-yl)methylene)-4-phenyl-1H-[1,5]benzodiazepin-2(3H)-one (3)
.
3-(2-Hydroxybenzoyl)-5-phenylpyrano[2,3-e][1,5]benzodiazepine (5)
To a solution of compound 3 (1.02 g, 2.6 mmol) in dioxane (25 mL), aqueous potassium hydroxide solution (25 mL, 50 mmol; 2M) was added. The alkaline solution was warmed at mL) to get a clear yellow solution. Acidification of the solution using dilute hydrochloric acid (0.5 M) till be red to litmus gave a pale yellow fine particles which was digested for 15 
General Procedure for Preparation of 3-(Diazolylmethyl-ene)benzodiazepinones 8 and 9
A mixture of compound 3 (0.78 g, 2 mmol) and hydrazine hydrate (0.1 mL, 2 mmol) or hydroxylamine hydrochloride (0.14 g, 2 mmol) was heated under reflux, in glacial acetic acid (20 mL), for 3 hrs. Then the reaction mixture was left to cool and the precipitate so formed was filtered, dried, washed with water and crystallized from ethanol. 
3-((5-(2-Hydroxyphenyl)-1H-pyrazol-4-yl)methylene)-4-phenyl-1H-[1,5]benzodiazepin-2(3H)-one (8)
